miRNA (duplex)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b9/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b9/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b8/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b8/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b7/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b7/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b6/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b6/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b5/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b5/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b4/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b4/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b3/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b3/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b2/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b2/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b1/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b1/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337b0/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337b0/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337af/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337af/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337ae/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337ae/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337ad/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337ad/5b6b3ecdc820301400b337ab.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3ee3c820301400b337ac/5b6b3ecdc820301400b337ab.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3ee3c820301400b337ac/5b6b3ecdc820301400b337ab.png"}]